Nkarta – Allogeneic CAR Natural Killer (NK) Cell Therapy
Paul Hastings, CEO of Nkarta Therapeutics discusses results from their NKX101 study, an allogeneic CAR Natural Killer (NK) cell therapy, in patients wit...
3308 articles
Paul Hastings, CEO of Nkarta Therapeutics discusses results from their NKX101 study, an allogeneic CAR Natural Killer (NK) cell therapy, in patients wit...
Noel Bairey Merz, MD, Director of the Barbra Streisand Women's Heart Center, the Linda Joy Pollin Women's Heart Health Program, the Erika J.
Julie Harper, board-certified dermatologist and Galderma consultant, discusses maskne, seasonal acne and related treatment options. She also discusses...
Lynda Szczech, VP of Clinical Development and Medical Affairs at FibroGen discusses new data presented at the American Society of Nephrology (ASN) Kidne...
Jenny Paul, CEO of Intent Entertainment and Executive Producer/Creator/Actor of "Adulting with Jane" discusses a special mental health episode called "D...
Boredom isn't fun, and a single minute can turn into a whole hour and an hour, which becomes difficult to quantify for most people.
Bob Hutchens, CEO of StemBioSys, Inc., developers of advanced stem cell technologies discusses research, which was recently published in peer-reviewed j...
Irina Anselm, MD, Director of the Mitochondrial Program and Co-Director of the Neurometabolic Program at Boston Children's Hospital discusses the ultra ...
LeRoy Graham, MD, Founder and Medical Director of Not One More Life Asthma Care Program discusses a new project to address health disparities among peop...
Harvey Kaufman, Senior Medical Director and head of the Health Trends™ Research Program at Quest Diagnostics discusses a recent study of the skyrocket...